Status:
COMPLETED
Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Autoimmune Hepatitis
Eligibility:
All Genders
16-65 years
Phase:
PHASE3
Brief Summary
Untreated Autoimmune hepatitis (AIH) is a progressive disease. Mainstay of treatment are corticosteroids (CS). In addition to being ineffective a substantial minority of cases, corticosteroid side-eff...
Eligibility Criteria
Inclusion
- 16-65 years old individuals with probable of definite AIH according to the revised AIH criteria.
- Willing and able to participate in the study
Exclusion
- Non-consenting patients
- decompensated cirrhosis, i.e. clinical ascites, hepatic encephalopathy, history of variceal bleeding
- Presence of serious concomitant cardiovascular, pulmonary or renal condition
- Presence of active malignant disorder
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT01170351
Start Date
December 1 2005
End Date
December 1 2018
Last Update
July 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Digestive Disease Research Center, Shariati Hospital
Tehran, Iran, 14117